Analysis reports sensitivity and specificity of detectable ctHPV-DNA in patients post-neoadjuvant chemotherapy, suggesting effectiveness of treatment monitoring.
Supplemental Table 4. Per-patient sensitivity and specificity of detectable ctHPV-DNA at 12 weeks or later following treatment.
No takes yet. Share an insight, caveat, or question.
Rosenberg et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: